Novo Integrated Sciences, Inc. Deferred Revenue
Novo Integrated Sciences, Inc. had Deferred Revenue of $38.56 thousand as of 2022-05-31, per its 10-Q filed 2022-07-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2022-07-14
- 2022-05-31: Deferred Revenue $38.56K.
- 2022-02-28: Deferred Revenue $38.63K.
- 2021-11-30: Deferred Revenue $38.31K.
- 2021-08-31: Deferred Revenue $38.63K.
| Period end | Deferred Revenue |
|---|---|
| 2022-05-31 | $38.56K 10-Q · filed 2022-07-14 |
| 2022-02-28 | $38.63K 10-Q · filed 2022-04-13 |
| 2021-11-30 | $38.31K 10-Q · filed 2022-01-18 |
| 2021-08-31 | $38.63K 10-Q · filed 2022-07-14 |
| 2020-08-31 | $39.43K 10-K · filed 2021-12-14 |